| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0002-3235-60 | 0002-3235 | HUMAN PRESCRIPTION DRUG | Cymbalta | Duloxetine hydrochloride | CAPSULE, DELAYED RELEASE | ORAL | 20040824 | 20261002 | NDA | NDA021427 | Eli Lilly and Company | DULOXETINE HYDROCHLORIDE | 20 mg/1 | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0002-3235-60) |
| 0002-3240-30 | 0002-3240 | HUMAN PRESCRIPTION DRUG | Cymbalta | Duloxetine hydrochloride | CAPSULE, DELAYED RELEASE | ORAL | 20040824 | 20260417 | NDA | NDA021427 | Eli Lilly and Company | DULOXETINE HYDROCHLORIDE | 30 mg/1 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0002-3240-30) |
| 0002-3240-90 | 0002-3240 | HUMAN PRESCRIPTION DRUG | Cymbalta | Duloxetine hydrochloride | CAPSULE, DELAYED RELEASE | ORAL | 20040824 | 20260417 | NDA | NDA021427 | Eli Lilly and Company | DULOXETINE HYDROCHLORIDE | 30 mg/1 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0002-3240-90) |